GlassScriptPhysician profile
Gregg R Sachs
NPI 1326119918
$844.83
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $334 · 2021: $152 · 2022: $257.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $323.93 | 2019-2022 | |
| Optinose US, INC. | $142.25 | 2019-2021 | |
| Glaxosmithkline, LLC. | $128.27 | 2020-2022 | |
| Intersect Ent, INC. | $61.44 | 2020 | |
| Neurent Medical Limited | $42.07 | 2022 | |
| Alk-Abello, INC | $33.40 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $26.07 | 2021 | |
| Aerin Medical INC. | $22.27 | 2019 | |
| Genzyme Corporation | $20.59 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.63 | 2022 | |
| Ethicon US, LLC | $14.78 | 2020 | |
| Smith+Nephew, INC. | $13.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Sachs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.